Eprosartan

Eprosartan is an angiotensin-II receptor antagonist with actions, uses and adverse effects similar to those of losartan. It has been introduced more recently and is used in the treatment of hypertension. Like other memebers of this class, it may be used as an alternative to an ACE inhibitor in the management of heart failure.

Brands
TEVETEN LEVEL
Adult Dose
Dose: 600 mg
Single Dose: 600 (600)
Frequency: 24 hourly
Route: PO
Instructions: If necessary increased after 2-3 wks to 800mg QD
Neonatal
Paedriatic
Characteristics
. It is of Synthetic origin and belongs to Imidazole. . The Molecular Weight of Eprosartan is 424.50.
Contraindications
Eprosartan is contraindicated in conditions like Pregnancy.
Effects
The symptomatic adverse reactions produced by Eprosartan are more or less tolerable and if they become severe, they can be treated symptomatically, these include Flatulence, Dizziness, Hypotension, Arthralgia, Rhinitis, Angioedema, Rarely anemia.
Indications
Eprosartan is primarily indicated in conditions like Hypertension, and can also be given in adjunctive therapy as an alternative drug of choice in Diabetic nephropathy, Heart failure.
Interactions
No data regarding the interactions of Eprosartan was found.
Interfrence
Risks
Drug should not be given to patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Renal impairment; breast feeding; use with caution in renal artery stenosis, aortic or mitral valve stenosis and in obstructive hypertrophic cardiomyopathy.Monitor plasma-potassium concentration, particularly in elderly and in patients with renal impairment; lower initial doses may be appropriate in these patients.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.